文献速递胸部肿瘤放疗姑息放疗与转移瘤

早期非小细胞肺癌患者获取多学科肿瘤会诊与治疗的机会差异:一项SEER-Medicare分析

Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-03-13

该横断面研究分析2016至2017年SEER-Medicare数据库中6120例I-IIA期非小细胞肺癌患者,采用多层多项逻辑回归评估患者特征及医师共享网络指标与多学科肿瘤会诊及初始治疗的关系,发现医师网络与多学科会诊和治疗选择相关。

要点

  • 6120例I-IIA期NSCLC患者中仅751例(12.3%)接受了多学科肿瘤会诊。
  • 居住在高比例「关键枢纽」外科医师医院转诊区域的患者更少接受多学科会诊。
  • 接受多学科会诊的患者接受立体定向体部放疗相对于手术的可能性为5.32倍(95%CI 4.27-6.63)。

核心结论

  • 医师网络与多学科肿瘤会诊的接受及治疗选择相关,提示可利用患者共享网络分析改善肺癌诊疗可及性。

研究设计与样本

  • 横断面研究,分析2016至2017年SEER-Medicare数据库中I-IIA期非小细胞肺癌患者数据。
  • 共纳入6120例患者,构建患者共享网络并识别局部唯一的肿瘤专科医师(关键枢纽)。
  • 计算每个医院转诊区域关键枢纽肿瘤专科医师比例作为专科稀缺性的网络指标。
  • 采用多层多项逻辑回归估计研究变量与多学科会诊的关系,多层逻辑回归分析多学科会诊与初始治疗的关系。

主要发现

  • 751例(12.3%)接受多学科肿瘤会诊,1729例(28.3%)仅咨询放射肿瘤科医师,2010例(32.8%)仅咨询外科医师,1630例(26.6%)在诊断后2个月内未咨询上述专科医师。
  • 与低比例关键枢纽外科医师的医院转诊区域相比,高比例区域的患者仅咨询放射肿瘤科医师相对于接受多学科会诊的相对风险为2.99(95%CI 1.87-4.78)。
  • 高比例关键枢纽外科医师区域的患者未咨询上述专科医师相对于接受多学科会诊的相对风险为2.70(95%CI 1.68-4.35)。
  • 接受多学科会诊的患者接受立体定向体部放疗相对于手术的可能性为5.32倍(95%CI 4.27-6.63)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Disparities in access to a multidisciplinary cancer consultation (MDCc) persist, and the role of physician relationships remains understudied. This study examined the extent to which multilevel factors, including patient characteristics and patient-sharing network measures reflecting the structure of physician relationships, are associated with an MDCc and receipt of stereotactic body radiation therapy versus surgery among patients with early-stage non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: In this cross-sectional study, we analyzed Surveillance, Epidemiology, and End Results (SEER)-Medicare data for patients diagnosed with stage I-IIA NSCLC from 2016 to 2017. We assembled patient-sharing networks and identified cancer specialists who were locally unique for their specialty, herein referred to as linchpins. The proportion of linchpin cancer specialists for each hospital referral region (HRR) was calculated as a network-based measure of specialist scarcity. We used multilevel multinomial logistic regression to estimate associations between study variables and receipt of an MDCc and multilevel logistic regression to examine the relationship between patient receipt of an MDCc and initial treatment. RESULTS: Our study included 6120 patients with stage I-IIA NSCLC, of whom 751 (12.3%) received an MDCc, 1729 (28.3%) consulted only a radiation oncologist, 2010 (32.8%) consulted only a surgeon, and 1630 (26.6%) consulted neither specialist within 2 months of diagnosis. Compared with patients residing in an HRR with a low proportion of linchpin surgeons, those residing in an HRR with a high proportion of linchpin surgeons had a 2.99 (95% CI, 1.87-4.78) greater relative risk of consulting only a radiation oncologist versus receiving an MDCc and a 2.70 (95% CI, 1.68-4.35) greater relative risk of consulting neither specialist versus receiving an MDCc. Patients who received an MDCc were 5.32 times (95% CI, 4.27-6.63) more likely to receive stereotactic body radiation therapy versus surgery. CONCLUSIONS: Physician networks are associated with receipt of an MDCc and treatment, underscoring the potential for leveraging patient-sharing network analysis to improve access to lung cancer care.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Liu YC, Schmidt RO, Kapadia NS, et al. Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis. Int J Radiat Oncol Biol Phys. 2024. PMID: 38490619. doi:10.1016/j.ijrobp.2024.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。